相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis
Olawale Ajose et al.
AIDS (2012)
Projected life expectancy of people with HIV according to timing of diagnosis
Fumiyo Nakagawa et al.
AIDS (2012)
Antiretroviral Treatment of Adult HIV Infection 2012 Recommendations of the International Antiviral Society-USA Panel
Melanie A. Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis
Ravindra K. Gupta et al.
LANCET (2012)
Optimising the manufacture, formulation, and dose of antiretroviral drugs for more cost-efficient delivery in resource-limited settings: a consensus statement
Keith W. Crawford et al.
LANCET INFECTIOUS DISEASES (2012)
Effectiveness and safety of 30 mg versus 40 mg stavudine regimens: a cohort study among HIV-infected adults initiating HAART in South Africa
Mhairi Maskew et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2012)
Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis
Nathan Ford et al.
AIDS (2011)
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
Myron S. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Similar efficacy and tolerability of atazanavir compared with atazanavir/ritonavir, each with abacavir/lamivudine after initial suppression with abacavir/lamivudine plus ritonavir-boosted atazanavir in HIV-infected patients
Kathleen E. Squires et al.
AIDS (2010)
Once-Daily Atazanavir/Ritonavir Compared With Twice-Daily Lopinavir/Ritonavir, Each in Combination With Tenofovir and Emtricitabine, for Management of Antiretroviral-Naive HIV-1-Infected Patients: 96-Week Efficacy and Safety Results of the CASTLE Study
Jean-Michel Molina et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
Pharmacokinetics of low-dose protease inhibitors and efavirenz in low- and middle-income countries
Meena Gorowara et al.
CURRENT OPINION IN HIV AND AIDS (2010)
Effect of Telmisartan on Renal Outcomes A Randomized Trial
Johannes F. E. Mann et al.
ANNALS OF INTERNAL MEDICINE (2009)
Designing and interpreting HIV noninferiority trials in naive and experienced patients
Andrew Hill et al.
AIDS (2008)
Efficacy and safety of atazanavir-based highly active antiretroviral therapy in patients with virologic suppression switched from a stable, boosted or unboosted protease inhibitor treatment regimen: The SWAN study (AI424-097) 48-week results
Jose Gatell et al.
CLINICAL INFECTIOUS DISEASES (2007)
Pharmacokinetics of saquinavir hard-gel/ritonavir and atazanavir when combined once daily in HIV type 1-infected individuals administered different atazanavir doses
Marta Boffito et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2006)
分享论文
